MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on January 23, 2008; DOI: 10.1124/mol.107.043117


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
mol.107.043117v1
73/4/1151    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Cropp, C. D.
Right arrow Articles by Giacomini, K. M.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cropp, C. D.
Right arrow Articles by Giacomini, K. M.


Received for publication November 1, 2007.
Revised January 22, 2008.
Accepted for publication January 23, 2008.

ORGANIC ANION TRANSPORTER 2 (SLC22A7) IS A FACILITATIVE TRANSPORTER OF cGMP

Cheryl D. Cropp 1, Takafumi Komori 1, James E. Shima 1, Thomas J. Urban 1, Sook Wah Yee 1, Swati More 1, Kathleen M. Giacomini 2*

1 University of California, San Francisco 2 University of California - San Francisco

* Address correspondence to: E-mail: kmg{at}itsa.ucsf.edu

Abstract

The second messenger, cGMP, mediates a host of cellular responses to various stimuli, resulting in the regulation of many critical physiologic functions. The existence of specific cGMP transporters on the plasma membrane that participate in the regulation of cGMP levels has been suggested in a large number of studies. In this study, we identified a novel plasma membrane transporter for cGMP. In particular, we show that hOAT2 (SLC22A7), a member of the solute carrier (SLC) superfamily, is a facilitative transporter for cGMP and other guanine nucleotides. hOAT2, which is ubiquitously expressed at high levels in many cell types, was previously thought to primarily transport organic anions. Among purine and pyrimidine nucleobases, nucleosides and nucleotides, hOAT2 showed the greatest preference for cGMP, which transported cGMP with a Km value of 88 ± 11 µM and exhibited between 50- and 100-fold enhanced uptake over control cells. Our data revealed that hOAT2, is a bidirectional facilitative transporter that can control both intracellular and extracellular levels of cGMP. Additionally, we observed that a common alternatively spliced variant of hOAT2 demonstrated a complete loss of transport function as a result of a low expression level on the plasma membrane. We conclude that hOAT2 is a highly efficient, facilitative transporter of cGMP and may be involved in cGMP signaling in many tissues. Our study suggests that hOAT2 represents a potential new drug target for regulating cGMP levels.


Key words: cGMP, Organic anion





Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2008 by the American Society for Pharmacology and Experimental Therapeutics